Anil Namboodiripad, Ph.D.

Anil Namboodiripad, Ph.D. Email and Phone Number

Chief Executive Officer at Script Biosciences Inc. @ Script Biosciences
Anil Namboodiripad, Ph.D.'s Location
Princeton, New Jersey, United States, United States
Anil Namboodiripad, Ph.D.'s Contact Details
About Anil Namboodiripad, Ph.D.

Executive and operating senior leadership experience in start-ups and publicly traded life sciences companies with track record in company formation, raising capital, strategy and business development, building and scaling R&D driven commercial businesses. Currently leading a VC backed pre-clinical stage company that is developing therapeutics based on its proprietary CRISPR based genome editing platform and a proprietary LNP based platform for delivery of genetic materials to the Central Nervous System. Prior track record in leading a commercial organization and clinical stage R&D pipeline. Oversaw approval of multiple NDAs and commercial product launches.Multi-disciplinary hands-on experience in managing R&D and product launch and commercialization (US P&L). Executed multiple early and commercial stage licensing transactions (>$500 MM) and R&D collaborations.Prior roles in international/global marketing (Abbvie and BMS) including new product launch (including launch of HUMIRA), portfolio and strategic planning. Also worked as a management consultant at Booz & co (Booz Allen Hamilton) addressing C-level business issues across multiple industry sectors.

Anil Namboodiripad, Ph.D.'s Current Company Details
Script Biosciences

Script Biosciences

View
Chief Executive Officer at Script Biosciences Inc.
Anil Namboodiripad, Ph.D. Work Experience Details
  • Script Biosciences
    Chief Executive Officer
    Script Biosciences Jun 2021 - Present
    Capital raise, strategic direction, pipeline expansion and value creation, building a world class R&D team and business development and transactionsScript Biosciences focuses on positively impacting lives of patients suffering from genetically driven debilitating diseases. We are aiming for potential cures for such diseases by harnessing the power of our proprietary non-viral delivery and gene editing technologieshttps://www.scriptbiosciences.com
  • Dr. Reddy'S Laboratories
    Sr. Vp/Head, Proprietary Products Business (Specialty Products)
    Dr. Reddy'S Laboratories Dec 2016 - May 2021
    Hyderabad, Ts, In
    Led R&D, business development and commercial operations for Proprietary Products through multiple NDA approvals and licensing transactions
  • Promius Pharma
    President
    Promius Pharma Dec 2016 - Jun 2019
    Led R&D, commercial operations and business development until the company's acquisition
  • Promius Pharma
    Vp/Svp, Portfolio Strategy, Planning And Commercialization, Proprietary Products
    Promius Pharma Jun 2011 - Nov 2016
  • Dr. Reddy'S Laboratories
    Senior Director , Corporate Development
    Dr. Reddy'S Laboratories Feb 2008 - Jun 2011
    Hyderabad, Ts, In
  • Bristol Myers Squibb
    Global Marketing - Anti-Virals
    Bristol Myers Squibb Feb 2006 - Jan 2008
    Lawrence Township, Nj, Us
    Global marketing in the anti-virals franchise
  • Abbvie
    International Marketing, Immunology/Auto-Immune Diseases (Humira Launch/Commercialization)
    Abbvie Jan 2002 - Feb 2006
    North Chicago, Illinois, Us
  • Abbott Laboratories
    New Product Planning/Global Commercialization Strategy
    Abbott Laboratories 2000 - 2002
    Abbott Park, Illinois, Us
  • Booz & Company
    Management Consultant
    Booz & Company 1997 - 2000
    New York, Ny, Us
    Conducted business case analysis and led client teams to address complex business issues leading to clear, actionable recommendations

Anil Namboodiripad, Ph.D. Skills

Pharmaceutical Industry Product Launch Strategy Biotechnology Commercialization Market Access Management Clinical Development Product Development Drug Development Pharmaceutics Strategic Partnerships Business Development Marketing Global Marketing Oncology Life Sciences Healthcare Medical Devices R&d International Marketing Research And Development Lifesciences

Anil Namboodiripad, Ph.D. Education Details

  • The University Of Texas Medical Branch
    The University Of Texas Medical Branch
    Physiology And Biophysics
  • The Wharton School
    The Wharton School
    Windhover Program

Frequently Asked Questions about Anil Namboodiripad, Ph.D.

What company does Anil Namboodiripad, Ph.D. work for?

Anil Namboodiripad, Ph.D. works for Script Biosciences

What is Anil Namboodiripad, Ph.D.'s role at the current company?

Anil Namboodiripad, Ph.D.'s current role is Chief Executive Officer at Script Biosciences Inc..

What is Anil Namboodiripad, Ph.D.'s email address?

Anil Namboodiripad, Ph.D.'s email address is an****@****rma.com

What is Anil Namboodiripad, Ph.D.'s direct phone number?

Anil Namboodiripad, Ph.D.'s direct phone number is +184766*****

What schools did Anil Namboodiripad, Ph.D. attend?

Anil Namboodiripad, Ph.D. attended The University Of Texas Medical Branch, The Wharton School.

What are some of Anil Namboodiripad, Ph.D.'s interests?

Anil Namboodiripad, Ph.D. has interest in Economic Empowerment, Environment, Science And Technology, Animal Welfare, Arts And Culture, Health.

What skills is Anil Namboodiripad, Ph.D. known for?

Anil Namboodiripad, Ph.D. has skills like Pharmaceutical Industry, Product Launch, Strategy, Biotechnology, Commercialization, Market Access, Management, Clinical Development, Product Development, Drug Development, Pharmaceutics, Strategic Partnerships.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.